Product NDC: | 0003-4215 |
Proprietary Name: | ONGLYZA |
Non Proprietary Name: | SAXAGLIPTIN |
Active Ingredient(s): | 5 mg/1 & nbsp; SAXAGLIPTIN |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0003-4215 |
Labeler Name: | E.R. Squibb & Sons, L.L.C. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022350 |
Marketing Category: | NDA |
Start Marketing Date: | 20090731 |
Package NDC: | 0003-4215-31 |
Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-4215-31) |
NDC Code | 0003-4215-31 |
Proprietary Name | ONGLYZA |
Package Description | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-4215-31) |
Product NDC | 0003-4215 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SAXAGLIPTIN |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20090731 |
Marketing Category Name | NDA |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | SAXAGLIPTIN HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] |